March 2021

Immunoinformatics analysis to design novel epitope based vaccine candidate targeting the glycoprotein and nucleoprotein of Lassa mammarenavirus (LASMV) using strains from Nigeria

Immunoinformatics analysis to design novel epitope based vaccine candidate targeting the glycoprotein and nucleoprotein of Lassa mammarenavirus (LASMV) using strains from Nigeria

Antibodies, Assay Kits, Biology Cells, Blog, cDNA, Clia Kits, Culture Cells, Devices, DNA, DNA Templates, Enzymes, Equipments, Exosomes, Gels, Isotypes, Medium & Serums, NATtrol, Particles, PCR, Pcr Kits, Recombinant Proteins, Ria Kits, RNA, Test Kits, Vector & Virus, Western Blot /

Lassa mammarenavirus (LASMV) is answerable for a particular sort of acute viral hemorrhagic fever generally known as Lassa fever. Lack of efficient therapies and counter-measures towards the virus has resulted in a excessive mortality fee in its endemic areas. Subsequently, on this research, a novel epitope-based vaccine has been designed utilizing the strategies of immunoinformatics […]

Immunoinformatics analysis to design novel epitope based vaccine candidate targeting the glycoprotein and nucleoprotein of Lassa mammarenavirus (LASMV) using strains from Nigeria Read More »

Development of multi-epitope peptide-based vaccines against SARS-CoV-2

Development of multi-epitope peptide-based vaccines against SARS-CoV-2

Antibodies, Assay Kits, Biology Cells, Blog, cDNA, Clia Kits, Culture Cells, Devices, DNA, Elisa Kits, Enzymes, Equipments, Exosomes, Gels, Isotypes, Medium & Serums, NATtrol, Particles, PCR, Pcr Kits, Recombinant Proteins, Ria Kits, RNA, Test Kits, Vector & Virus, Western Blot /

Extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated a pandemic involving so excess of 32 million infections and 980,031 deaths. Efficient vaccines are urgently wanted to stop SARS-CoV-2 infections. No vaccines have but been accepted for licensure by regulatory businesses. Although host immune responses to SARS-CoV-2 infections are starting to be unravelled, efficient clearance

Development of multi-epitope peptide-based vaccines against SARS-CoV-2 Read More »